Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Akvile Statnickaite"'
Autor:
Sigita Liutkauskiene, Saulius Grizas, Kristina Jureniene, Jorune Suipyte, Akvile Statnickaite, Elona Juozaityte
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background The objective of study was to determine the effect of anthracycline dose reduction and chemotherapy delays on 5-year overall survival in patients with stage I-III breast cancer, to establish the impact of molecular subtypes on the
Externí odkaz:
https://doaj.org/article/2fd5cfa4acec4389a7548c29e00dd08a
Autor:
Akvile Statnickaite, Kristina Jureniene, Jorune Suipyte, Sigita Liutkauskiene, Elona Juozaityte, Saulius Grizas
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
BMC Cancer
BMC Cancer
Background The objective of study was to determine the effect of anthracycline dose reduction and chemotherapy delays on 5-year overall survival in patients with stage I-III breast cancer, to establish the impact of molecular subtypes on the anthracy
Autor:
Liutkauskiene, Sigita, Grizas, Saulius, Jureniene, Kristina, Jorune Suipyte, Akvile Statnickaite, Juozaityte, Elona
Table S1. Cox proportional hazards model on 5-year survival when impact of tumor size, molecular subtype and menopausal status were adjusted in four patients groups. (DOC 31 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4051077e7f6e118edd7613db910d240f
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 206:e110
Autor:
Rasa Janciauskiene, Kristina Jureniene, Elona Juozaityte, Akvile Statnickaite, Saulius Grizas, Sigita Liutkauskiene, J. Suipyte
Publikováno v:
Annals of Oncology. 25:iv101
Aim: The relation between chemotherapy dose intensity and patient outcome in the management of early stage breast cancer is still arguable. Randomised trials showed benefit of full standard doses of chemotherapy on schedule. The aim of this study is
Autor:
Viktoras Rudžianskas, Artūras Inčiūra, Saulius Vaitkus, Evaldas Padervinskis, Milda Rudžianskienė, Rita Kupčinskaitė-Noreikienė, Lina Saltonaitė, Alius Noreika, Akvilė Statnickaitė, Elona Juozaitytė
Publikováno v:
Medicina, Vol 50, Iss 2, Pp 92-99 (2014)
Background and objective: In the last decade, the number of publications that report on the use of external beam radiotherapy and high-dose-rate brachytherapy (HDR-BRT) in the treatment of recurrent head and neck cancer has increased, but no studies
Externí odkaz:
https://doaj.org/article/d4ebc5756cc54d19a4454d194e610a30